|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/10/18 Emmaus Life Sciences, Inc. 10-Q 6/30/18 60:4.5M S2 Filings LLC/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 453K
2: EX-10.2 Material Contract HTML 18K
3: EX-31.1 Certification -- §302 - SOA'02 HTML 21K
4: EX-31.2 Certification -- §302 - SOA'02 HTML 22K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 19K
12: R1 Document and Entity Information HTML 44K
13: R2 Condensed Consolidated Balance Sheets (Unaudited) HTML 123K
14: R3 Condensed Consolidated Balance Sheets HTML 46K
(Parenthetical)
15: R4 Unaudited Condensed Consolidated Statements of HTML 75K
Operations
16: R5 Unaudited Condensed Consolidated Statements of HTML 109K
Cash Flows
17: R6 Organization, Nature of Operations and Going HTML 30K
Concern Uncertainty
18: R7 Summary of Significant Accounting Policies HTML 85K
19: R8 Accounts Receivable HTML 24K
20: R9 Long - Term Borrowings and Other Note Payables HTML 23K
21: R10 Acquisition HTML 55K
22: R11 Stockholders'Equity HTML 159K
23: R12 Convertible Preferred Stock HTML 35K
24: R13 Income Taxes HTML 26K
25: R14 Related Party Transactions HTML 24K
26: R15 Loss Per Share HTML 45K
27: R16 Commitments and Contingent Liabilities HTML 32K
28: R17 Summary of Significant Accounting Policies HTML 155K
(Policies)
29: R18 Summary of Significant Accounting Policies HTML 30K
(Tables)
30: R19 Accounts Receivable (Tables) HTML 23K
31: R20 Acquisition (Tables) HTML 49K
32: R21 Stockholders' Equity (Tables) HTML 117K
33: R22 Loss Per Share (Tables) HTML 44K
34: R23 Commitments and Contingent Liabilities (Tables) HTML 26K
35: R24 Organization, Nature of Operations and Going HTML 30K
Concern Uncertainty (Details Narrative)
36: R25 Summary of Significant Accounting Policies HTML 24K
(Details)
37: R26 Summary of Significant Accounting Policies HTML 32K
(Details 1)
38: R27 Summary of Significant Accounting Policies HTML 68K
(Details Narrative)
39: R28 Accounts Receivable (Details) HTML 26K
40: R29 Long - Term Borrowings and Other Note Payables HTML 48K
(Details Narrative)
41: R30 Acquisition (Details) HTML 64K
42: R31 Acquisition (Details 1) HTML 27K
43: R32 Acquisition (Details Narrative) HTML 55K
44: R33 Stockholders' Equity (Details) HTML 31K
45: R34 Stockholders' Equity (Details 1) HTML 24K
46: R35 Stockholders' Equity (Details 2) HTML 52K
47: R36 Stockholders' Equity (Details 3) HTML 38K
48: R37 Stockholders' Equity (Details 4) HTML 31K
49: R38 Stockholders' Equity (Details 5) HTML 53K
50: R39 Stockholders' Equity (Details Narrative) HTML 225K
51: R40 Stockholders' Equity (Details Narrative 1) HTML 40K
52: R41 Convertible Preferred Stock (Details Narrative) HTML 54K
53: R42 Income Taxes (Details Narrative) HTML 37K
54: R43 Related Party Transactions (Details Narrative) HTML 33K
55: R44 Loss Per Share (Details) HTML 39K
56: R45 Commitments and Contingent Liabilities (Details) HTML 22K
57: R46 Commitments and Contingent Liabilities (Details HTML 37K
Narrative)
59: XML IDEA XML File -- Filing Summary XML 105K
58: EXCEL IDEA Workbook of Financial Reports XLSX 82K
6: EX-101.INS XBRL Instance -- mynd-20180630 XML 1.29M
8: EX-101.CAL XBRL Calculations -- mynd-20180630_cal XML 156K
9: EX-101.DEF XBRL Definitions -- mynd-20180630_def XML 562K
10: EX-101.LAB XBRL Labels -- mynd-20180630_lab XML 903K
11: EX-101.PRE XBRL Presentations -- mynd-20180630_pre XML 733K
7: EX-101.SCH XBRL Schema -- mynd-20180630 XSD 132K
60: ZIP XBRL Zipped Folder -- 0001615774-18-007848-xbrl Zip 139K
EXHIBIT 31.2
Certification of CFO Pursuant to
Securities
Exchange Act Rules 13a-14 and 15d-14
as Adopted Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002
I, Donald D’Ambrosio, certify that:
1. I have reviewed this quarterly report on Form 10-Q of MYnd Analytics, Inc..;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date:
August 10, 2018
/s/ Donald D’Ambrosio
Name: Donald D’Ambrosio
Title: Chief Financial Officer (Principal Financial Officer)
C:
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 8/10/18 | None on these Dates | ||
| For Period end: | 6/30/18 | |||
| List all Filings | ||||